Life Sciences revenues rose 3 percent year over year to $7.33 billion from $7.14 billion. Diagnostic revenues increased 2 percent to $9.79 billion from $9.58 billion, while Biotechnology revenues ...
For Q1 2025, Danaher said it expects core revenues will decline in the low-single digit percent range year over year. For full-year 2025, the company anticipates core revenues will increase ...
Life Sciences revenues rose 3 percent year over year to $7.33 billion from $7.14 billion. Diagnostic revenues increased 2 percent to $9.79 billion from $9.58 billion, while Biotechnology revenues ...
The test, which is intended for assessing cardiovascular risk, is the first lipoprotein (a), or Lp(a) test measured in nanomoles per liter to receive FDA clearance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback